IVAX PHARMACEUTICALS NV, LLC
PARSIPPANY, NJ

IVAX PHARMACEUTICALS NV, LLC is an Active company incorporated on June 26, 2013 with the registered number L13000092093. This Florida Limited Liability company is located at 400 Interpace Parkway, Parsippany, NJ, 07054, US and has been running for twelve years. There are currently three active principals.

KEY FACTS ABOUT IVAX PHARMACEUTICALS NV, LLC

  1. US Businesses
  2. Companies in Florida
  3. Leon County Companies
Company name
IVAX PHARMACEUTICALS NV, LLC
Status
Active
Filed Number
L13000092093
FEI Number
65-0547890
Date of Incorporation
June 26, 2013
Age - 12 years
Home State
FL
Company Type
Florida Limited Liability

IVAX PHARMACEUTICALS NV, LLC NEAR ME

Principal Address
400 Interpace Parkway,
Parsippany,
NJ,
07054,
US

See Also

IVAX LABORATORIES PUERTO RICO, INC. IVAX LLC IVAX PHARMACEUTICALS, LLC IVAYE EXPRESS LLC IVAYLA LLC

Officers and Directors

The IVAX PHARMACEUTICALS NV, LLC managed by the three persons from Parsippany, West Chester on following positions: President, Manager, VP,

Christine Fox

Position
President Active
From
Parsippany, NJ, NJ
Christine Fox Related Companies
  1. COBALT LABORATORIES, LLC
  2. IVAX PHARMACEUTICALS, LLC
  3. ACTAVIS LLC
  4. ANESTA, LLC
  5. ACTAVIS TOTOWA LLC
  6. IVAX LLC

Sharon Barber-Lui

Position
Manager Active
From
Parsippany, NJ, NJ
Sharon Barber-Lui Related Companies
  1. IVAX PHARMACEUTICALS, LLC
  2. IVAX LLC
  3. WATSON MANUFACTURING SERVICES, INC.
  4. TEVA NEUROSCIENCE, INC.
  5. TEVA RESPIRATORY, LLC
  6. IVAX LABORATORIES PUERTO RICO, INC.

Brian Shanahan

Position
VP, Active
From
West Chester, PA, PA
Brian Shanahan Related Companies
  1. ANDA PUERTO RICO INC.
  2. NUPATHE INC.
  3. COBALT LABORATORIES, LLC
  4. IVAX PHARMACEUTICALS, LLC
  5. ACTAVIS LLC
  6. BARR INTERNATIONAL SERVICES, INC.



Registered Agent is CORPORATION SERVICE COMPANY

Address
1201 HAYS STREET, TALLAHASSEE, FL, 32301, 2525

Events

May 12, 2022
LC STMNT OF RA/RO CHG
December 20, 2013
MERGER
December 19, 2013
MERGER
June 26, 2013
CONVERSION

Annual Reports

2024
May 1, 2024
2023
April 28, 2023